182 related articles for article (PubMed ID: 354519)
1. Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester.
Huston AC; Hoeprich PD
Antimicrob Agents Chemother; 1978 Jun; 13(6):905-9. PubMed ID: 354519
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Hoeprich PD; Huston AC
J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
Meunier F; Lambert C; Van der Auwera P
J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
[TBL] [Abstract][Full Text] [Related]
4. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
Hoeprich PD; Huston AC
J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123
[TBL] [Abstract][Full Text] [Related]
6. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Ellis NS; Bartlett MS; Smith JW
Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
Lombardi G; Gramegna G; Cavanna C; Poma G; Marangoni E; Michelone G
Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
9. Disk agar diffusion susceptibility testing of yeasts.
Saubolle MA; Hoeprich PD
Antimicrob Agents Chemother; 1978 Oct; 14(4):517-30. PubMed ID: 568910
[TBL] [Abstract][Full Text] [Related]
10. Comparative susceptibility of Candida albicans to amphotericin B and amphotericin B methyl ester.
Bannatyne RM; Cheung R
Antimicrob Agents Chemother; 1977 Oct; 12(4):449-50. PubMed ID: 335958
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of clotrimazole (Bay b 5097).
Shadomy S
Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
Gadebusch HH; Pansy F; Klepner C; Schwind R
J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
Ralph ED; Khazindar AM; Barber KR; Grant CW
Antimicrob Agents Chemother; 1991 Jan; 35(1):188-91. PubMed ID: 2014976
[TBL] [Abstract][Full Text] [Related]
14. Effects of ascorbic acid on the antifungal action of amphotericin B.
Brajtburg J; Elberg S; Kobayashi GS; Medoff G
J Antimicrob Chemother; 1989 Sep; 24(3):333-7. PubMed ID: 2681119
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of amphotericin B, hamycin and their novel water-soluble compounds against pathogenic yeasts.
Sekhon AS; Padhye AA; Garg AK; Hamir Z
Chemotherapy; 1992; 38(5):297-302. PubMed ID: 1286573
[TBL] [Abstract][Full Text] [Related]
16. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
[TBL] [Abstract][Full Text] [Related]
18. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
[TBL] [Abstract][Full Text] [Related]
20. New medium for in vitro susceptibility studies with amphotericin B.
Utz CJ; White S; Shadomy S
Antimicrob Agents Chemother; 1976 Oct; 10(4):776-7. PubMed ID: 791112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
